 Paul Menard-Katcher
Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 15 | 2024 | 325 | 2.100 |
Why?
| | Esophagus | 7 | 2024 | 255 | 1.080 |
Why?
| | Hernia, Hiatal | 3 | 2022 | 35 | 0.860 |
Why?
| | Esophageal Motility Disorders | 3 | 2020 | 27 | 0.820 |
Why?
| | Gastroenterology | 5 | 2021 | 181 | 0.560 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 51 | 0.540 |
Why?
| | Eosinophilia | 4 | 2022 | 218 | 0.440 |
Why?
| | Myotomy | 2 | 2023 | 13 | 0.420 |
Why?
| | Patient Reported Outcome Measures | 3 | 2024 | 402 | 0.420 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 15 | 0.390 |
Why?
| | Laryngopharyngeal Reflux | 2 | 2021 | 15 | 0.360 |
Why?
| | Colonoscopy | 3 | 2024 | 245 | 0.350 |
Why?
| | Gastritis | 3 | 2022 | 108 | 0.340 |
Why?
| | Enteritis | 3 | 2022 | 103 | 0.340 |
Why?
| | Eosinophils | 4 | 2024 | 332 | 0.330 |
Why?
| | Manometry | 3 | 2020 | 95 | 0.330 |
Why?
| | Endoscopy, Digestive System | 3 | 2020 | 136 | 0.290 |
Why?
| | Clinical Competence | 6 | 2024 | 1094 | 0.280 |
Why?
| | Deglutition Disorders | 2 | 2022 | 143 | 0.260 |
Why?
| | Quality of Life | 5 | 2024 | 2878 | 0.250 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2024 | 89 | 0.210 |
Why?
| | Zenker Diverticulum | 1 | 2023 | 12 | 0.210 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2023 | 34 | 0.210 |
Why?
| | Esophageal Achalasia | 1 | 2023 | 30 | 0.200 |
Why?
| | Severity of Illness Index | 3 | 2024 | 2822 | 0.200 |
Why?
| | Colonic Polyps | 1 | 2024 | 88 | 0.200 |
Why?
| | Learning Curve | 2 | 2020 | 72 | 0.190 |
Why?
| | Hyperplasia | 2 | 2020 | 175 | 0.190 |
Why?
| | Balloon Occlusion | 1 | 2022 | 34 | 0.190 |
Why?
| | Tetraspanins | 1 | 2021 | 19 | 0.190 |
Why?
| | Prospective Studies | 9 | 2024 | 7573 | 0.180 |
Why?
| | Esophageal Stenosis | 1 | 2021 | 54 | 0.180 |
Why?
| | Adult | 18 | 2024 | 37643 | 0.180 |
Why?
| | Simulation Training | 1 | 2022 | 99 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2024 | 275 | 0.170 |
Why?
| | Interleukin-13 | 1 | 2021 | 149 | 0.170 |
Why?
| | Male | 22 | 2024 | 67330 | 0.170 |
Why?
| | Child | 13 | 2024 | 21819 | 0.160 |
Why?
| | Fellowships and Scholarships | 3 | 2021 | 303 | 0.160 |
Why?
| | Sensitivity and Specificity | 1 | 2024 | 1936 | 0.160 |
Why?
| | Female | 21 | 2024 | 72816 | 0.150 |
Why?
| | Competency-Based Education | 2 | 2020 | 73 | 0.150 |
Why?
| | Cytokines | 2 | 2020 | 2084 | 0.150 |
Why?
| | Humans | 31 | 2024 | 136803 | 0.150 |
Why?
| | Middle Aged | 13 | 2024 | 33239 | 0.150 |
Why?
| | Self Report | 2 | 2024 | 822 | 0.150 |
Why?
| | Barrett Esophagus | 1 | 2020 | 149 | 0.140 |
Why?
| | Child, Preschool | 7 | 2024 | 10997 | 0.140 |
Why?
| | Proton Pump Inhibitors | 2 | 2021 | 109 | 0.130 |
Why?
| | Colon | 1 | 2019 | 282 | 0.130 |
Why?
| | Esophagoscopy | 3 | 2024 | 209 | 0.130 |
Why?
| | Parents | 3 | 2024 | 1340 | 0.130 |
Why?
| | Fibroblasts | 1 | 2021 | 993 | 0.130 |
Why?
| | Endothelial Cells | 1 | 2021 | 778 | 0.120 |
Why?
| | Colitis | 1 | 2019 | 266 | 0.120 |
Why?
| | Transition to Adult Care | 1 | 2017 | 81 | 0.120 |
Why?
| | Education, Medical, Graduate | 2 | 2022 | 481 | 0.120 |
Why?
| | Adolescent | 9 | 2024 | 21385 | 0.120 |
Why?
| | Microbiota | 1 | 2022 | 762 | 0.110 |
Why?
| | Curriculum | 2 | 2022 | 976 | 0.100 |
Why?
| | Basophils | 1 | 2013 | 73 | 0.100 |
Why?
| | Young Adult | 6 | 2024 | 13129 | 0.100 |
Why?
| | Aged | 7 | 2024 | 23808 | 0.100 |
Why?
| | Leukocyte Count | 2 | 2024 | 329 | 0.090 |
Why?
| | Internship and Residency | 1 | 2021 | 1133 | 0.090 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 5744 | 0.080 |
Why?
| | Endoscopy, Gastrointestinal | 2 | 2022 | 228 | 0.080 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5424 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1322 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2016 | 3540 | 0.070 |
Why?
| | Glucocorticoids | 1 | 2012 | 593 | 0.070 |
Why?
| | Accreditation | 2 | 2020 | 82 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 69 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 3286 | 0.060 |
Why?
| | Esophageal Mucosa | 1 | 2024 | 22 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2605 | 0.060 |
Why?
| | Colitis, Ulcerative | 1 | 2006 | 137 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2023 | 10748 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 14 | 0.050 |
Why?
| | Program Evaluation | 2 | 2020 | 889 | 0.050 |
Why?
| | Fluticasone | 1 | 2023 | 90 | 0.050 |
Why?
| | Fundoplication | 1 | 2022 | 53 | 0.050 |
Why?
| | Stomach | 1 | 2022 | 110 | 0.050 |
Why?
| | Herniorrhaphy | 1 | 2022 | 60 | 0.050 |
Why?
| | Adenoma | 1 | 2024 | 230 | 0.050 |
Why?
| | Time Factors | 1 | 2012 | 6809 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 7 | 0.050 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.050 |
Why?
| | Printing, Three-Dimensional | 1 | 2022 | 94 | 0.050 |
Why?
| | Pepsin A | 1 | 2021 | 19 | 0.050 |
Why?
| | Heartburn | 1 | 2021 | 12 | 0.050 |
Why?
| | Phenotype | 2 | 2021 | 3189 | 0.040 |
Why?
| | Dilatation | 1 | 2021 | 66 | 0.040 |
Why?
| | Gene Silencing | 1 | 2021 | 195 | 0.040 |
Why?
| | International Cooperation | 1 | 2021 | 198 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 207 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 7 | 0.040 |
Why?
| | Cough | 1 | 2021 | 122 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2006 | 1396 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 5704 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2021 | 622 | 0.040 |
Why?
| | Feedback | 1 | 2019 | 172 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 169 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2019 | 132 | 0.040 |
Why?
| | Diagnostic Errors | 1 | 2019 | 170 | 0.040 |
Why?
| | United States | 3 | 2023 | 14691 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2829 | 0.030 |
Why?
| | Colorectal Neoplasms | 1 | 2024 | 791 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 951 | 0.030 |
Why?
| | Patient Discharge | 1 | 2022 | 894 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2017 | 562 | 0.030 |
Why?
| | Gene Expression | 1 | 2020 | 1500 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1481 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1124 | 0.030 |
Why?
| | Self Care | 1 | 2017 | 375 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2023 | 5106 | 0.030 |
Why?
| | Benchmarking | 1 | 2015 | 183 | 0.030 |
Why?
| | Neutralization Tests | 1 | 2013 | 75 | 0.030 |
Why?
| | Machine Learning | 1 | 2018 | 488 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1616 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2751 | 0.020 |
Why?
| | Data Collection | 1 | 2015 | 668 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2020 | 15510 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2013 | 342 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1772 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1269 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3434 | 0.020 |
Why?
| | Animals | 2 | 2023 | 36850 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2013 | 1430 | 0.020 |
Why?
| | Ki-67 Antigen | 1 | 2006 | 111 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 10332 | 0.020 |
Why?
| | Epithelium | 1 | 2006 | 311 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2006 | 397 | 0.010 |
Why?
| | Regeneration | 1 | 2006 | 195 | 0.010 |
Why?
| | DNA Damage | 1 | 2006 | 420 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 4282 | 0.010 |
Why?
| | Kinetics | 1 | 2006 | 1664 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5750 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 621 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2006 | 1094 | 0.010 |
Why?
| | Mice | 1 | 2013 | 17759 | 0.010 |
Why?
| | Inflammation | 1 | 2006 | 2835 | 0.010 |
Why?
|
|
Menard-Katcher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|